Skip to main content
Top
Published in: Breast Cancer Research 1/2015

Open Access 01-12-2015 | Poster presentation

Can public consultation effectively optimise the design of a patient information leaflet about breast magnetic resonance imaging?

Authors: Lyn Jones, Anna Mankelow, Joanne Robson, Anjum Mahatma, Alice Pocklington, Alexandra Valencia

Published in: Breast Cancer Research | Special Issue 1/2015

Login to get access

Excerpt

Breast magnetic resonance imaging (MRI) involves multiple aspects that are unique to a medical environment and may seem frightening and strange to a person from a non-medical background (the tunnel, no credit cards, keys or watches, loud noises, intravenous pump injector). The purpose of an information leaflet is to inform people about what they should expect, and to prepare them for the experience. During public consultation about breast MRI, we discovered that women considered the current information provided by the NHS (from several different hospitals) to be inadequate. They told us that their experience of the process of breast MRI had been more distressing that it would have been had they been better informed. We decided to ask their advice on the design of an information leaflet to see if it could be optimised to better prepare women for the experience. …
Metadata
Title
Can public consultation effectively optimise the design of a patient information leaflet about breast magnetic resonance imaging?
Authors
Lyn Jones
Anna Mankelow
Joanne Robson
Anjum Mahatma
Alice Pocklington
Alexandra Valencia
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2015
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3775

Other articles of this Special Issue 1/2015

Breast Cancer Research 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine